Hillard CJ and Campbell WB |
Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. |
1997 |
J. Lipid Res. |
pmid:9458263
|
Pratt PF et al. |
N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. |
1998 |
Am. J. Physiol. |
pmid:9458889
|
Goparaju SK et al. |
Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. |
1998 |
FEBS Lett. |
pmid:9475172
|
Sulcova E et al. |
Biphasic effects of anandamide. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9476980
|
Adams IB et al. |
Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9495885
|
Giuffrida A and Piomelli D |
Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. |
1998 |
FEBS Lett. |
pmid:9498819
|
Van der Kloot W et al. |
Calcitonin gene-related peptide acts presynaptically to increase quantal size and output at frog neuromuscular junctions. |
1998 |
J. Physiol. (Lond.) |
pmid:9508830
|
Di Marzo V et al. |
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. |
1998 |
Biochem. J. |
pmid:9512456
|
Calignano A et al. |
Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. |
1997 |
Eur. J. Pharmacol. |
pmid:9537804
|
Richardson JD et al. |
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. |
1998 |
Pain |
pmid:9539680
|
Salzet M et al. |
Leech immunocytes contain proopiomelanocortin: nitric oxide mediates hemolymph proopiomelanocortin processing. |
1997 |
J. Immunol. |
pmid:9548480
|
Randall MD and Kendall DA |
Endocannabinoids: a new class of vasoactive substances. |
1998 |
Trends Pharmacol. Sci. |
pmid:9550942
|
Kimura T et al. |
Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. |
1998 |
Biol. Pharm. Bull. |
pmid:9556149
|
Soderstrom K et al. |
Discovery of novel cannabinoid receptor ligands from diverse marine organisms. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9561107
|
Qureshi J et al. |
Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol. |
1998 |
Mol. Cell. Biochem. |
pmid:9562238
|
Derocq JM et al. |
The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. |
1998 |
FEBS Lett. |
pmid:9563506
|
Axelrod J and Felder CC |
Cannabinoid receptors and their endogenous agonist, anandamide. |
1998 |
Neurochem. Res. |
pmid:9566594
|
Prevot V et al. |
Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. |
1998 |
Brain Res. |
pmid:9593913
|
Richardson JD et al. |
Antihyperalgesic effects of spinal cannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9600630
|
Stefano GB |
Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release. |
1998 |
J. Neuroimmunol. |
pmid:9610675
|